Business & Finance
Sanofi Global Health unveils non-profit Impact brand
4 July 2022 - Sanofi Global Health, part of French healthcare company Sanofi S.A. (Euronext Paris:SAN), announced on Monday the launch of a new non-profit brand of standard of care medicines produced ...
Oxford Biomedica signs extended deal to make AstraZeneca COVID-19 vaccine
1 July 2022 - Gene and cell therapy company Oxford Biomedica plc (LSE:OXB) announced on Friday the signing of a new three-year agreement with pharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN)...
Eli Lilly and Company announces Q3 2022 dividend
28 June 2022 - Eli Lilly and Company (NYSE: LLY), a United States-based pharmaceutical company, announced on Monday its dividend for the third quarter of 2022.The company declared a dividend of USD0.9...
AbbVie announces quarterly cash dividend
24 June 2022 - United States-based pharmaceutical company AbbVie Inc. (NYSE: ABBV) announced on Thursday its quarterly cash dividend.The company has declared dividend of USD1.41 per share.The cash div...
Shionogi Inks Deal with NHS England to Begin a Subscription Payment Model Reimbursement of Cefiderocol in England
16 June 2022 - - Japan-based pharmaceutical company Shionogi and Co., Ltd's European subsidiary, Shionogi B.V. has signed an agreement with NHS England to begin a subscription payment model reimb...
Global Access Diagnostics Formed to Expand Affordable Access to Advanced Rapid Diagnostic Technologies
16 June 2022 - - UK-based Global Access Health, a social enterprise focused on providing affordable medical products for global health, has formally introduced its first portfolio company, Global Acce...